Parecoxib Sodium — CAS 198470-85-8

Parecoxib Sodium is the sodium salt form of parecoxib, a selective COX-2 inhibitor prodrug. It is formulated for parenteral administration and used for the short-term management of acute postoperative pain. Mediocon Inc manufactures this API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• IV/IM parenteral treatment of acute postoperative pain
• Perioperative pain management as part of multimodal analgesia
• Post-surgical pain after cardiac, orthopedic and general surgery
• Opioid-sparing analgesic therapy in the perioperative setting

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support